The World Health Organisation has approved a South Korean pharmaceutical company, EUbiologics, as a third manufacturer of cholera vaccine. This is meant to increase the annual number of doses to 6 million to meet global demand.
The World Health Organisation has approved a South Korean pharmaceutical company, EUbiologics, as a third manufacturer of cholera vaccine. This is meant to increase the annual number of doses to 6 million to meet global demand.
No Comments